BioMed Realty has made a big long-term bet on demand in San Diego’s life science sector with a $255M acquisition of Pfizer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback